NIPC Law

Omalizumab structure Authors  Manav Segal, Jeffrey R Stokes, Thomas B. Casale Licence CC BY 2,5 Source Wikimedia Commons Jane Lambert Patents Court (HH Judge Hacon)  Celltrion Inc v Genentech, Inc and another [2025] EWHC 174 (Pat) (30 Jan 2025)   This was an action by Celltrion Inc ("Celltrion") for the revocation of European patent (UK)  3 805 248 B1  for a "Process for concentration of antibodies and therapeutic products thereof" ("the patent") held by Genentech Inc ("Genentech") and Novartis AG ("Novartis") and a counterclaim by Genentech and Novartis against Celltrion and its UK subsidiary for infringement.  The action and counterclaim were tried by His Honour Judge Hacon between 24 Oct 2024 and 1 Nov 2024.  The learned judge delivered judgment on 30 Jan 2025 (see  Celltrion Inc v Genentech, Inc and another  [2025] EWHC 174 (Pat) (30 Jan 2025)).  By para [193] of his judgment, he found that the patent was valid and infringed. Th...

Ceric Oxide Author Walkerma  Reproduced with kind permission of the copyright owner  Jane Lamber t Court of Appeal (Lords Justices Lewison, Floyd and Jackson)  Anan Kasei Co Ltd and another v Neo Chemicals and Oxides Ltd and another [ 2019] WLR(D) 553, [2019] EWCA Civ 1646 Patents Court (Roger Wyand QC)  Anan Kasei Co. Ltd and another v Molycorp Chemicals & Oxides (Europe) Ltd .  [2018] EWHC 843 (Pat) In    Anan Kasei Co. Ltd and another v Molycorp Chemicals & Oxides (Europe) Ltd . [2018] EWHC 843 (Pat), Anan Kasei Co. Ltd the proprietor of  European patent 1435338  and Rhodia Operations SAS, its exclusive licensee, sued a distributor of catalytic products for infringement of claims 1 to 5 of the  patent.  The defendant, which changed its name to    Neo Chemicals and Oxides (Europe) Ltd., denied infringement and counterclaimed for revocation on grounds of anticipation, obv...